CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 28.25
-0.20 (-0.70%)
Jan 22, 2026, 1:12 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 6.09 billion as of January 21, 2026. Its market cap has decreased by -46.02% in one year.
Market Cap
6.09B
Enterprise Value
3.88B
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.25
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 6.09B, a decrease of -59.41%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 6.20B | 3.02% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 7.39B |
| OBI Pharma | 6.80B |
| Savior Lifetec | 6.41B |
| Pharmosa Biopharm | 6.27B |
| Sinphar Pharmaceutical | 5.86B |
| Steminent Biotherapeutics | 5.81B |
| Locus Cell | 5.79B |
| Panion & Bf Biotech | 5.46B |